Deal Snapshot
ACON INVESTMENTS, HUMUS CAPITAL PARTNER TO ACQUIRE BIOSIDUS
Wednesday 13 June 2018

Affiliates of Washington, US-based ACON Latin America Opportunities Fund IV, L.P., in partnership with Argentina-based private equity firm Humus Capital Partners (HCP) have acquired a majority equity interest in Argentina-based biosimilar pharmaceuticals distributor Biosidus S.A. and Biosidus Farma S.A. the company said.

ACON and HCP will continue Biosidus' international expansion strategy, building on its track record of more than 150 m doses of biosimilar pharmaceuticals produced over the last two decades.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 13/06/2018
Target: Biosidus S.A. and Biosidus Farma/majority stake
Country: Argentina
Sector: Pharmaceuticals
Type: LBO
Financing:
Status: Agreed
Vendor:
Buyer: ACON Latin America Opportunities Fund IV, Humus Capital Partners
Comment:
Terms of the deal were not disclosed

Options